Currently, Surgepays Inc [SURG] is trading at $1.8, down -2.70%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The SURG shares have gain 11.11% over the last week, with a monthly amount drifted -6.25%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Surgepays Inc [NASDAQ: SURG] stock has seen the most recent analyst activity on March 13, 2024, when Maxim Group downgraded its rating to a Hold.
This stock has fluctuated between a low of $1.05 and a high of $3.47 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Surgepays Inc [NASDAQ: SURG] shares were valued at $1.8 at the most recent close of the market. An investor can expect a potential return of 455.56% based on the average SURG price forecast.
Analyzing the SURG fundamentals
Trailing Twelve Months sales for Surgepays Inc [NASDAQ:SURG] were 50.37M which represents 291.65% growth. Gross Profit Margin for this corporation currently stands at -0.39% with Operating Profit Margin at -0.79%, Pretax Profit Margin comes in at -0.84%, and Net Profit Margin reading is -0.83%. To continue investigating profitability, this company’s Return on Assets is posted at -2.9, Equity is -9.95 and Total Capital is 12.49. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -1.94.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.7039 points at the first support level, and at 1.6077 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.9223, and for the 2nd resistance point, it is at 2.0445.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Surgepays Inc [NASDAQ:SURG] is 0.52. Also, the Quick Ratio is 0.41, while the Cash Ratio stands at 0.16. Considering the valuation of this stock, the price to sales ratio is 0.75.
Transactions by insiders
Recent insider trading involved May David Allen, Director, that happened on Dec 10 ’25 when 38422.0 shares were purchased. Officer, Evers Anthony George completed a deal on Dec 04 ’25 to buy 0.18 million shares. Meanwhile, Director May David Allen sold 63000.0 shares on Jun 06 ’25.
